15 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
, and shall be the exclusive venue for resolution of, any dispute, claim or controversy of any nature arising out of or relating to this Agreement.
(g
SC14D9C
EX-99.2
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
contemplated hereby.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
SC14D9C
EX-99.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
contemplated hereby.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
SC14D9C
EX-99.3
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
contemplated hereby.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
8-K
EX-99.2
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
contemplated hereby.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
8-K
EX-99.3
6dco8us
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.1
frvfe7
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-1.1
7td7hp0
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
m38aqwxtw2yu tq
1 Jul 22
Shelf registration
4:13pm
424B3
EX-10.1
6i8sosoln7npk 5d9
12 Nov 21
Prospectus supplement
8:41am
8-K
EX-10.2
e4hrmwuu
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
S-4/A
EX-10.16
8ssr4j6xeh0q6u22uv
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.16
em5pva5
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
oy3 iv138x
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next